BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1065 related articles for article (PubMed ID: 32081875)

  • 1. Exploiting horizontal pleiotropy to search for causal pathways within a Mendelian randomization framework.
    Cho Y; Haycock PC; Sanderson E; Gaunt TR; Zheng J; Morris AP; Davey Smith G; Hemani G
    Nat Commun; 2020 Feb; 11(1):1010. PubMed ID: 32081875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An iterative approach to detect pleiotropy and perform Mendelian Randomization analysis using GWAS summary statistics.
    Zhu X; Li X; Xu R; Wang T
    Bioinformatics; 2021 Jun; 37(10):1390-1400. PubMed ID: 33226062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.
    Verbanck M; Chen CY; Neale B; Do R
    Nat Genet; 2018 May; 50(5):693-698. PubMed ID: 29686387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mendelian randomization accounting for correlated and uncorrelated pleiotropic effects using genome-wide summary statistics.
    Morrison J; Knoblauch N; Marcus JH; Stephens M; He X
    Nat Genet; 2020 Jul; 52(7):740-747. PubMed ID: 32451458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the potential role of pleiotropy in Mendelian randomization studies.
    Hemani G; Bowden J; Davey Smith G
    Hum Mol Genet; 2018 Aug; 27(R2):R195-R208. PubMed ID: 29771313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weak and pleiotropy robust sex-stratified Mendelian randomization in the one sample and two sample settings.
    Karageorgiou V; Tyrrell J; Mckinley TJ; Bowden J
    Genet Epidemiol; 2023 Mar; 47(2):135-151. PubMed ID: 36682072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Causal inference for heritable phenotypic risk factors using heterogeneous genetic instruments.
    Wang J; Zhao Q; Bowden J; Hemani G; Davey Smith G; Small DS; Zhang NR
    PLoS Genet; 2021 Jun; 17(6):e1009575. PubMed ID: 34157017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mendelian randomization accounting for complex correlated horizontal pleiotropy while elucidating shared genetic etiology.
    Cheng Q; Zhang X; Chen LS; Liu J
    Nat Commun; 2022 Oct; 13(1):6490. PubMed ID: 36310177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bias in two-sample Mendelian randomization when using heritable covariable-adjusted summary associations.
    Hartwig FP; Tilling K; Davey Smith G; Lawlor DA; Borges MC
    Int J Epidemiol; 2021 Nov; 50(5):1639-1650. PubMed ID: 33619569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementing MR-PRESSO and GCTA-GSMR for pleiotropy assessment in Mendelian randomization studies from a practitioner's perspective.
    Ong JS; MacGregor S
    Genet Epidemiol; 2019 Sep; 43(6):609-616. PubMed ID: 31045282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profile-likelihood Bayesian model averaging for two-sample summary data Mendelian randomization in the presence of horizontal pleiotropy.
    Shapland CY; Zhao Q; Bowden J
    Stat Med; 2022 Mar; 41(6):1100-1119. PubMed ID: 35060160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extending the MR-Egger method for multivariable Mendelian randomization to correct for both measured and unmeasured pleiotropy.
    Rees JMB; Wood AM; Burgess S
    Stat Med; 2017 Dec; 36(29):4705-4718. PubMed ID: 28960498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extending Causality Tests with Genetic Instruments: An Integration of Mendelian Randomization with the Classical Twin Design.
    Minică CC; Dolan CV; Boomsma DI; de Geus E; Neale MC
    Behav Genet; 2018 Jul; 48(4):337-349. PubMed ID: 29882082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing and controlling for horizontal pleiotropy with probabilistic Mendelian randomization in transcriptome-wide association studies.
    Yuan Z; Zhu H; Zeng P; Yang S; Sun S; Yang C; Liu J; Zhou X
    Nat Commun; 2020 Jul; 11(1):3861. PubMed ID: 32737316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mendelian randomization for causal inference accounting for pleiotropy and sample structure using genome-wide summary statistics.
    Hu X; Zhao J; Lin Z; Wang Y; Peng H; Zhao H; Wan X; Yang C
    Proc Natl Acad Sci U S A; 2022 Jul; 119(28):e2106858119. PubMed ID: 35787050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian variable selection with a pleiotropic loss function in Mendelian randomization.
    Gkatzionis A; Burgess S; Conti DV; Newcombe PJ
    Stat Med; 2021 Oct; 40(23):5025-5045. PubMed ID: 34155684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostics for Pleiotropy in Mendelian Randomization Studies: Global and Individual Tests for Direct Effects.
    Dai JY; Peters U; Wang X; Kocarnik J; Chang-Claude J; Slattery ML; Chan A; Lemire M; Berndt SI; Casey G; Song M; Jenkins MA; Brenner H; Thrift AP; White E; Hsu L
    Am J Epidemiol; 2018 Dec; 187(12):2672-2680. PubMed ID: 30188971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome.
    Greco M FD; Minelli C; Sheehan NA; Thompson JR
    Stat Med; 2015 Sep; 34(21):2926-40. PubMed ID: 25950993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring and mitigating potential bias when genetic instrumental variables are associated with multiple non-exposure traits in Mendelian randomization.
    Yang Q; Sanderson E; Tilling K; Borges MC; Lawlor DA
    Eur J Epidemiol; 2022 Jul; 37(7):683-700. PubMed ID: 35622304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes.
    Yang C; Fagan AM; Perrin RJ; Rhinn H; Harari O; Cruchaga C
    Genome Med; 2022 Dec; 14(1):140. PubMed ID: 36510323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.